http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SK-8222000-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_00c917cdf93c76be481a3f5e8f5b6850 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6929 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-543 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
| filingDate | 1998-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54e0e3fca8b4127d9a29715a51b09d27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22f5290cbd84ffed89f0121287f58931 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03ec64d75390542b04a48afefd7b9115 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3eb38f9818686cb7a5d7ac7972f6a3d9 |
| publicationDate | 2000-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | SK-8222000-A3 |
| titleOfInvention | Transfection particles for delivery of nucleic acid into higher eucaryotic cells i(in vitro) and i(in vivo) comprises one or more nucleic acid, pharmaceutical composition comprising them and a kit |
| abstract | Transfection particles for delivery of nucleic acid into higher eucaryotic cells in vitro and in vivo comprises one or more nucleic acid molecules condensed by organic cationic molecules. The discrete and stable particles are obtained by complexing the nucleic acid molecules with identical or different organic cationic precursor molecules without crosslinking nucleic acid molecules, and covalently linking the precursor molecules to each other on the nucleic acid template. For specific cellular targeting, the particles may carry targeting molecules, e.g. sugars. Preferred cationic precursor molecules are lipophilic detergents that are linked to form lipids. The particles contain preferably only one nucleic acid molecule which makes them useful for gene therapy and for delivery of large DNA molecules. <IMAGE> |
| priorityDate | 1997-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 197.